CA2025010A1 - Polyurethane elastomers of low hardness - Google Patents
Polyurethane elastomers of low hardnessInfo
- Publication number
- CA2025010A1 CA2025010A1 CA 2025010 CA2025010A CA2025010A1 CA 2025010 A1 CA2025010 A1 CA 2025010A1 CA 2025010 CA2025010 CA 2025010 CA 2025010 A CA2025010 A CA 2025010A CA 2025010 A1 CA2025010 A1 CA 2025010A1
- Authority
- CA
- Canada
- Prior art keywords
- thermoplastic polyurethane
- polyester
- omega
- alpha
- dicarboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229920003225 polyurethane elastomer Polymers 0.000 title abstract description 10
- 229920000728 polyester Polymers 0.000 claims abstract description 44
- 239000004433 Thermoplastic polyurethane Substances 0.000 claims abstract description 34
- 229920002803 thermoplastic polyurethane Polymers 0.000 claims abstract description 34
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 18
- 239000012948 isocyanate Substances 0.000 claims abstract description 11
- 150000002513 isocyanates Chemical class 0.000 claims abstract description 11
- 239000005056 polyisocyanate Substances 0.000 claims abstract description 11
- 229920001228 polyisocyanate Polymers 0.000 claims abstract description 10
- 150000002009 diols Chemical group 0.000 claims abstract description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- -1 ester carbonate Chemical class 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 4
- 239000013638 trimer Substances 0.000 claims description 4
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 3
- 230000001588 bifunctional effect Effects 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 229920000570 polyether Polymers 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- CZZYITDELCSZES-UHFFFAOYSA-N diphenylmethane Chemical compound C=1C=CC=CC=1CC1=CC=CC=C1 CZZYITDELCSZES-UHFFFAOYSA-N 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- 239000000539 dimer Substances 0.000 claims 1
- 229920002635 polyurethane Polymers 0.000 description 18
- 239000004814 polyurethane Substances 0.000 description 18
- 235000014113 dietary fatty acids Nutrition 0.000 description 15
- 239000000194 fatty acid Substances 0.000 description 15
- 229930195729 fatty acid Natural products 0.000 description 15
- 150000004665 fatty acids Chemical class 0.000 description 14
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 11
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 8
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 6
- KYXHKHDZJSDWEF-LHLOQNFPSA-N CCCCCCC1=C(CCCCCC)C(\C=C\CCCCCCCC(O)=O)C(CCCCCCCC(O)=O)CC1 Chemical compound CCCCCCC1=C(CCCCCC)C(\C=C\CCCCCCCC(O)=O)C(CCCCCCCC(O)=O)CC1 KYXHKHDZJSDWEF-LHLOQNFPSA-N 0.000 description 5
- 235000011037 adipic acid Nutrition 0.000 description 4
- 239000001361 adipic acid Substances 0.000 description 4
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 3
- 239000000806 elastomer Substances 0.000 description 3
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- WTPYFJNYAMXZJG-UHFFFAOYSA-N 2-[4-(2-hydroxyethoxy)phenoxy]ethanol Chemical compound OCCOC1=CC=C(OCCO)C=C1 WTPYFJNYAMXZJG-UHFFFAOYSA-N 0.000 description 2
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 2
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- 125000005442 diisocyanate group Chemical group 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 2
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 2
- WGACMNAUEGCUHG-VYBOCCTBSA-N (2s)-2-[[(2s)-2-[[(2s)-2-acetamidopropanoyl]amino]propanoyl]amino]-n-[(2s)-6-amino-1-[[(2s)-1-[(2s)-2-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-[[(2s)-6-amino-1-[[(2s)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy- Chemical compound CC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N)=O)CC1=CC=C(O)C=C1 WGACMNAUEGCUHG-VYBOCCTBSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- OVBFMUAFNIIQAL-UHFFFAOYSA-N 1,4-diisocyanatobutane Chemical compound O=C=NCCCCN=C=O OVBFMUAFNIIQAL-UHFFFAOYSA-N 0.000 description 1
- VZXPHDGHQXLXJC-UHFFFAOYSA-N 1,6-diisocyanato-5,6-dimethylheptane Chemical compound O=C=NC(C)(C)C(C)CCCCN=C=O VZXPHDGHQXLXJC-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
- JWQRAVLDBQBSFK-UHFFFAOYSA-N 2-[5-(2-hydroxyethoxy)naphthalen-1-yl]oxyethanol Chemical compound C1=CC=C2C(OCCO)=CC=CC2=C1OCCO JWQRAVLDBQBSFK-UHFFFAOYSA-N 0.000 description 1
- KUZSBKJSGSKPJH-VXGBXAGGSA-N 5-[(9R)-6-[(3R)-3-methylmorpholin-4-yl]-11-oxa-1,3,5-triazatricyclo[7.4.0.02,7]trideca-2,4,6-trien-4-yl]pyrazin-2-amine Chemical compound C[C@@H]1COCCN1c1nc(nc2N3CCOC[C@H]3Cc12)-c1cnc(N)cn1 KUZSBKJSGSKPJH-VXGBXAGGSA-N 0.000 description 1
- MITGKKFYIJJQGL-UHFFFAOYSA-N 9-(4-chlorobenzoyl)-6-methylsulfonyl-2,3-dihydro-1H-carbazol-4-one Chemical compound ClC1=CC=C(C(=O)N2C3=CC=C(C=C3C=3C(CCCC2=3)=O)S(=O)(=O)C)C=C1 MITGKKFYIJJQGL-UHFFFAOYSA-N 0.000 description 1
- 239000004604 Blowing Agent Substances 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 239000005058 Isophorone diisocyanate Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- DNNXXFFLRWCPBC-UHFFFAOYSA-N N=C=O.N=C=O.C1=CC=CC=C1 Chemical compound N=C=O.N=C=O.C1=CC=CC=C1 DNNXXFFLRWCPBC-UHFFFAOYSA-N 0.000 description 1
- INWVTRVMRQMCCM-UHFFFAOYSA-N N=C=O.N=C=O.C=1C=CC=CC=1C(C)(C)C1=CC=CC=C1 Chemical compound N=C=O.N=C=O.C=1C=CC=CC=1C(C)(C)C1=CC=CC=C1 INWVTRVMRQMCCM-UHFFFAOYSA-N 0.000 description 1
- GQSIVKYXTYPKIX-UHFFFAOYSA-N N=C=O.N=C=O.C=1C=CC=CC=1C(Cl)(Cl)C1=CC=CC=C1 Chemical compound N=C=O.N=C=O.C=1C=CC=CC=1C(Cl)(Cl)C1=CC=CC=C1 GQSIVKYXTYPKIX-UHFFFAOYSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- YIMQCDZDWXUDCA-UHFFFAOYSA-N [4-(hydroxymethyl)cyclohexyl]methanol Chemical compound OCC1CCC(CO)CC1 YIMQCDZDWXUDCA-UHFFFAOYSA-N 0.000 description 1
- KXBFLNPZHXDQLV-UHFFFAOYSA-N [cyclohexyl(diisocyanato)methyl]cyclohexane Chemical compound C1CCCCC1C(N=C=O)(N=C=O)C1CCCCC1 KXBFLNPZHXDQLV-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001339 alkali metal compounds Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- KORSJDCBLAPZEQ-UHFFFAOYSA-N dicyclohexylmethane-4,4'-diisocyanate Chemical compound C1CC(N=C=O)CCC1CC1CCC(N=C=O)CC1 KORSJDCBLAPZEQ-UHFFFAOYSA-N 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940124589 immunosuppressive drug Drugs 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 108010074544 myelin peptide amide-12 Proteins 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 description 1
- GLZWNFNQMJAZGY-UHFFFAOYSA-N octaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCO GLZWNFNQMJAZGY-UHFFFAOYSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000002889 oleic acids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 238000006456 reductive dimerization reaction Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 150000003606 tin compounds Chemical class 0.000 description 1
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/65—Low-molecular-weight compounds having active hydrogen with high-molecular-weight compounds having active hydrogen
- C08G18/66—Compounds of groups C08G18/42, C08G18/48, or C08G18/52
- C08G18/6633—Compounds of group C08G18/42
- C08G18/6637—Compounds of group C08G18/42 with compounds of group C08G18/32 or polyamines of C08G18/38
- C08G18/664—Compounds of group C08G18/42 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/3203
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/10—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
- C08G18/4205—Polycondensates having carboxylic or carbonic ester groups in the main chain containing cyclic groups
- C08G18/423—Polycondensates having carboxylic or carbonic ester groups in the main chain containing cyclic groups containing cycloaliphatic groups
- C08G18/4233—Polycondensates having carboxylic or carbonic ester groups in the main chain containing cyclic groups containing cycloaliphatic groups derived from polymerised higher fatty acids or alcohols
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Polyurethanes Or Polyureas (AREA)
- Materials For Medical Uses (AREA)
Abstract
Mo3449 LeA 27,126 POLYURETHANE ELASTOMERS OF LOW HARDNESS
ABSTRACT OF THE DISCLOSURE
This invention relates to substantially linear thermoplastic polyurethanes prepared by a process comprising reacting organic polyisocyanates; at least one polyester derivative having at least two isocyanate reactive hydrogen atoms, wherein said polyester derivative is a polyester of an .alpha.,.omega.-dicarboxylic acid containing a total of at least 16 carbon atoms and a non-vicinal diol, in an amount such that the proportion of the .alpha.,.omega.-dicarboxylic acid is greater than 35% by weight based on the total quantity of thermoplastic polyurethane; and chain lengthening agents having no phenolic OH groups. This invention also relates to the process used to prepare such thermoplastic polyurethanes.
This invention further relates to the use of the thermoplastic polyurethanes for medical purposes.
Mo3449
ABSTRACT OF THE DISCLOSURE
This invention relates to substantially linear thermoplastic polyurethanes prepared by a process comprising reacting organic polyisocyanates; at least one polyester derivative having at least two isocyanate reactive hydrogen atoms, wherein said polyester derivative is a polyester of an .alpha.,.omega.-dicarboxylic acid containing a total of at least 16 carbon atoms and a non-vicinal diol, in an amount such that the proportion of the .alpha.,.omega.-dicarboxylic acid is greater than 35% by weight based on the total quantity of thermoplastic polyurethane; and chain lengthening agents having no phenolic OH groups. This invention also relates to the process used to prepare such thermoplastic polyurethanes.
This invention further relates to the use of the thermoplastic polyurethanes for medical purposes.
Mo3449
Description
2Q2~9 Mo3449 LeA 27,126 POLYURETHANE ELASTOMERS OF LOW HARDNESS
BACKGROUND OF THE INVENTION
This invention relates to polyurethane elastomers of low hardness, to a process for their preparation, and to their 5 use.
The hardness values obtainable with polyurethane elastomers prepared according to known methods are in the range of about 80 Shore A to 75 Shore D and thus cover a range from typical rubber elastomers (20 to 80 Shore A) to rigid synthetic resins (greater than 55 Shore D).
Hardness is determined mainly by the proportion of the hard phase formed by the isocyanate and chain lengthening agent. At values below 80 Shore A, properties are markedly deteriorated. If the proportion of hard phase is reduced while 15 the polydiol content is kept constant, the dimensional - stability under heat deteriorates because of the partial miscibility of the hard phase with the polydiol component. If the hard phase component is reduced due to an increase in the mGlecular weight of the polydiol component, the flexibility of 20 the product in the cold deteriorates because of the increasing tendency to crystallization of the polydiols with increasing molecular weight. See also Becker/Braun, Kunststoffhandbuch, Volume 7, Polyurethane, page 36, Carl Hanser Verlag, Munich, Vienna, 1983.
2s Matrix materials of great hardness are disclosed in German Offenlegungsschrift 3,513,980. These materials are obtainable by the reaction of isocyanates, phenolic chain lengthening agents, and soft segment formers based on dimerized and/or trimerized fatty acids. The use of a dimeric fatty acid 3~ polyol with a high trimer content in a polyurethane lacquer which has improved resistance to chemicals is described in U.S.
Patent 3,349,049. The introduction of small proportions of dimeric fatty acid polyols is described in European Application 35376RH0609 . .
BACKGROUND OF THE INVENTION
This invention relates to polyurethane elastomers of low hardness, to a process for their preparation, and to their 5 use.
The hardness values obtainable with polyurethane elastomers prepared according to known methods are in the range of about 80 Shore A to 75 Shore D and thus cover a range from typical rubber elastomers (20 to 80 Shore A) to rigid synthetic resins (greater than 55 Shore D).
Hardness is determined mainly by the proportion of the hard phase formed by the isocyanate and chain lengthening agent. At values below 80 Shore A, properties are markedly deteriorated. If the proportion of hard phase is reduced while 15 the polydiol content is kept constant, the dimensional - stability under heat deteriorates because of the partial miscibility of the hard phase with the polydiol component. If the hard phase component is reduced due to an increase in the mGlecular weight of the polydiol component, the flexibility of 20 the product in the cold deteriorates because of the increasing tendency to crystallization of the polydiols with increasing molecular weight. See also Becker/Braun, Kunststoffhandbuch, Volume 7, Polyurethane, page 36, Carl Hanser Verlag, Munich, Vienna, 1983.
2s Matrix materials of great hardness are disclosed in German Offenlegungsschrift 3,513,980. These materials are obtainable by the reaction of isocyanates, phenolic chain lengthening agents, and soft segment formers based on dimerized and/or trimerized fatty acids. The use of a dimeric fatty acid 3~ polyol with a high trimer content in a polyurethane lacquer which has improved resistance to chemicals is described in U.S.
Patent 3,349,049. The introduction of small proportions of dimeric fatty acid polyols is described in European Application 35376RH0609 . .
2~25~ ~
156,665 (corresponding to U.S. Patent 4,602 079). The proportion of dimeric fatty acid is at most 35% by weight. The use of higher proportions of predominantly dimeric fatty acid is not obvious since it is known that large proportions of polydiols having a predominantly aliphatic character, such as OH-terminated polybutadiene or its hydrogenated form, give rise to materials that have only moderate mechanical properties ("strength") caused by poor miscibility with the hard phase.
Houben-Weyl, Handbuch der organischen Chemie, Volume E20, pages o 1569 and 1599.
Isocyanate-modified polyesters based on a glycol and a polymeric fatty acid are disclosed in U.S. Patent 3,264,236.
Soft polyurethane elastomers having high dimensional stability under heat, excellent flexibility in the cold, and high elasticity have not, however, been previously known in the art.
It is an object of the present invention to provide soft, highly elastic polyurethane elastomers having high dimensional stability under heat and excellent flexibility in the cold.
SUMMARY OF THE INVENTION
This invention relates to thermoplastic polyurethanes that are at least substantially linear in structure prepared by a process comprising reacting (aJ organic polyisocyanates;
(b) at least one polyester derivative having at least two isocyanate reactive hydrogen atoms, wherein said polyester derivative is a polyester of an ~ dicarboxylic acid containing a total of at least 16 carbon atoms and a non-vicinal diol, in an amount such that the proportion of the ~,~-dicarboxylic acid is greater than 35% by weight based on the total quantity of thermoplastic polyurethane;
and (c) chain lengthening agents having no phenolic OH groups.
Mo3449 2 ~ 2 ~
Catalysts, other known addltives, and other isocyanate-reactive compounds having a molecular weight greater than 400 may optionally be included in the preparation of the thermoplastic polyurethanes of the invention.
This invention further relates to a process for the preparation of thermoplastic polyurethanes having a substantially linear structure by the reaction of the organic polyisocyanates (a) with the polyester derivatives (b) and the chain lengthening agents (c).
Yet another object of this invention is the use of the thermoplastic polyurethanes according to the invention for medical purposes.
DETAILED DESCRIPTION OF THE INVENTION
In a preferred embodiment, the thermoplastic polyurethanes according to the invention have a hardness of less than about 80 Shore A, preferably less than 75 Shore A.
These thermoplastic polyurethanes are substantially linear and preferably have a volume flow index ("MVI") of at least 0.3 cm3/10 min (preferably at least 1 cm3/10 min), as determined at l9O-C with a testing force of 10 kp (DIN 53735; ISO 1132).
Preferred polyester derivatives (b) are polyesters, polyester carbonates, polyetheresters, and polyetherester carbonates containing terminal OH or NH2 groups. Particularly preferred polyesters (b) have an acid number below about 2 and a hydroxyl number of from about 11 to about 170.
Preferred ~ dicarboxylic acids used to prepare the polyester derivatives (b) include dimeric fatty acids obtained by reductive dimerization of unsaturated aliphatic monocarboxylic acids, preferably monocarboxylic acids having about 8 to about 22 carbon atoms and most preferably oleic acids. The trimer content formed in the reaction is no more than about 5% by weight based on the dimeric fatty acid, preferably no more than 1.5% by weight.
The polyester derivatives (b) to be used according to the invention may be obtained in known manner by condensation Mo3449 2~2~
of ~ dicarboxylic acids with non-vicinal diols, optionally with the addition of diaryl or dialkyl carbonates or phosgene.
The OH end groups obtained in the reaction may optionally be replaced by NH2 groups.
~he polyester derivatives to be used according to the invention may contain other aliphatic dicarboxylic acids in addition to the dimeric acids (for example, glutaric acid, adipic acid, suberic acid, azelaic acid, sebacic acid, dodecane diacid, or mixtures thereof), but pure dimeric acid is o preferably used. Examples of non-vicinal diols suitable for the condensation reaction include ethylene glycol, 1,3- and 1,2-propanediol, di-, tri-, tetra-, and octa-ethylene glycol, dipropylene glycol, tripropylene glycol, 1,4-butanediol, 1,3-and 1,5-pentanediol, 2,2-dimethyl-1,3-propanediol, 1,6-hexanediol, and higher, optionally branched, aliphatic diols. The molecular weights of components (b) may be from about 700 to about 10,000.
The organic polyisocyanates (a) include those used in previously known processes and are described e.g. in 20 . Kunststoff-handbuch, Volume VII, Polyurethane, Hanser Verlag, Munich, 1983, or in Houben-Weyl, Makromolekulare Stoffe, Volume E20. Aromatic or aliphatic diisocyanates, especially bis(iso-cyanatophenyl)methane, are preferably used. Other diiso-cyanates, however, may also be used, including aliphatic diisocyanates such as tetra- or hexamethylene diisocyanate, trimethylhexamethylene diisocyanate; cycloaliphatic diiso-cyanates such as cyclohexyl diisocyanate, isophorone diiso-cyanate or dicyclohexylmethane diisocyanate; or aromatic diiso-cyanates such as benzene diisocyanate, toluene diisocyanate, dichlorodiphenylmethane diisocyanate, dimethyldiphenylmethane diisocyanate, or dibenzyldiisocyanate.
The chain lengthening agents (c) are preferably bifunctional polyols such as ethylene glycol, propylene glycol, 1,4-butanediol, 1,5-pentanediol, 1,6-hexanediol, 1,4-cyclo-hexanedimethanol, hydroquinone-bis(2-hydroxyethyl) ether, and Mo3449 2~2 1,5-bis(2-hydroxyethoxy)naphthalene. The preferred ch~in lengthening agents have a molecular weight of from about 32 to about 399~ preferably from 62 to 220.
In one particularly preferred embodiment~ polyiso-cyanate (a~ is an isocyanate based on diphenylmethane and the chain lengthening agent (c) is butanediol.
In another preferred embodiment, components (a), (b), and (c) are substantially bifunctional and from about 0.9 to about 1.2 equivalents of isocyanate-reactive compounds are used per isocyanate equivalent.
Known catalysts, such as organic or inorganic tin compounds, amines, or alkali metal compounds, are optionally used for the preparation of polyurethanes. Other additives, such as blowing agents, stabilizers, emulsifiers, dyes, pigments, and fillers may also be used in known manner.
The thermoplastic polyurethanes according to the invention may be prepared by various methods. In one preferred embodiment, the polyurethane thermoplast is prepared by the band or screw process. See Becker/Braun, Kunststoff-Handbuch, Volume 7, Polyurethane, Chapter 8.2.1, pages 428 et seq, Carl Hanser Verlag, Munich, Vienna, 1983. A double screw kneading machine is used in a preferred embodiment.
The polyurethane-forming components may be introduced into the extruder at one feed point or at several feed points.
The components may be introduced into the screw machine either separately or as a pre-mix. See German Offenlegungsschrift 2,842,806. In a particularly preferred process, a prepolymer is first formed from isocyanate (a) and polyester derivative (b) and the chain lengthening agent is then added to the 30 prepolymer.
Apart from the low hardness and high elasticity compared with polyurethane elastomers prepared without dimeric fatty acids or with only small proportions of dimeric fatty acids, the polyurethane elastomers according to the invention 35 are also distinguished by their good compatibility with body Mo3449 2~ 2 ~. Q ~ ~
tissues and blood, which is due to the reduced surface tension, and their great durability when in contact with body fluids.
The elastomers of the invention are therefore particularly suitable for the manufacture of medical equipment such as blood bags, catheters, pacemaker leads, and artificial blood vessels or tubes to be inserted intravenously. Pharmacologically valuable substances may be incorporated in the materials, in particular anti-coagulants such as heparin, immunosuppressive drugs, antibiotics, or other known pharmacologically active o ingredients described, for example, in Polymer Science and Technology, Volume 34, "Polymers in Medicine IIn, Plenum Press, New York, 1983.
The following examples further illustrate details for the preparation of the compositions of this invention. The invention, which is set forth in the foregoing disclosure, is not to be limited either in spirit or scope by these examples.
Those skilled in the art will readily understand that known variations of the conditions and processes of the following preparative procedures can be used to prepare these 20 - compositions. Unless otherwise noted, all temperatures are degrees Celsius and all percentages are percentages by weight.
EXAMPLES
General Method of Preparation: Polyester component (b) (having compositions as described below) (0.~5 mole) was reacted with the total quantity of bis(4-isocyanatophenyl)-methane ("MDI~) (or other polyisocyanate, if indicated) at 100-C to form a prepolymer. The quantity of chain lengthening agent (c) equivalent to the remaining NCO groups was added to the melt at 110 C and the mi~ture was briefly degassed, poured into a mold, and tempered at llO-C for 8 hours. Plates 1 or 2 mm in thickness were produced by compression molding at 200-C
for determination of mechanical properties.
Comparison examples were prepared using a polyester diol of adipic acid and butanediol (OH number of 49.7) instead of component (b).
Mo3~49 2~23~ ~
The low hardness of the polyurethanes according to the invention is evident from the following Examples.
~xamPle 1 The procedure described above was carried out using 5 butanedio~ as the chain lengthening agent (c) and as component (b) a polyester having an OH number of 49.2 prepared from (1) hydrogenated dimeric fatty acid with acid number 197 (trimer content 1% and monomer content 0.1%) and (2) butanediol. The dimeric fatty acid had been obtained by dimerization of fatty acids and contains 36 carbon atoms (CAS Registry Number 68783-41-5, iodide value of 7).
The data listed in the following Table show that the thermoplastic polyurethanes obtained were surprisingly soft, in view of the percentage content of hard segment.
g MDI g Butane- Polyester X Hard Hardness diol OH number segment Shore A Shore D
37.5 9 49.2 28.92 80 28 13.5 49.2 35.71 85 30 62.5 18 50.7 41.32 89 39 22.5 50.7 46.88 92 44 Similar properties were obtained using as component ~b) a similar polyester having an OH number of 50.7.
When an adipic acid polyester having an OH number of 49.7 is used instead of the polyester derivative to be used according to the invention, the product obtained with the same proportion of hard segment is less soft.
Example 2 A thermoplastic polyurethane was prepared as described in Example 1 except that the polyester (b) was a polyester having an OH number 37. The resultant thermoplastic polyurethane had the following properties:
Mo344g 2 ~
% Hard segment: 23.5 Shore A hardness: 72 Tensile strength: 17 MPa Melting point of hard segment: 150C
Brittleness point: -40C
Example 3 A thermoplastic polyurethane was prepared as described in Example 1 except that the polyester (b) was a polyester having an OH number 28 prepared from the dimeric fatty acid from Example 1 and neopentyl glycol. The resultant thermoplastic polyurethane had the following properties:
% Hard segment: 19 Shore A hardness: 61 Tensile strength: 12 MPa Melting point of hard segment: 145C
Brittleness point: -40C
Thermoplastic polyurethanes having the degree of softness shown in Examples 2 and 3 are not obtained when conventional polyols are used. A polyurethane prepared from 20 the comparison polyester of Example 1 and containing a hard segment proportion of 20.8% by weight had a Shore A hardness of 94.
Example 4 A polyester having an OH number of 34.8 prepared from 25 the dimeric acid from Example 1 and ethylene glycol was used as component (b). The resultant polyurethane had a hard segment content of 22.4% and a Shore A hardness of 60.
Example 5 A polyester having an OH number of 27.0 prepared from 30 the dimeric acid from Example I and hexanediol was allowed to react with hexamethylene diisocyanate instead of bis(4-iso-cyanatophenyl)methane with the aid of butanediol as chain lengthening agent. The resultant product had a hard segment content of 14.2% and a Shore A hardness of 66.
Mo3449 2 ~ Q ~ ~
Example 6 Example 5 was repeated but using 1,4-bis(2-hydroxy-ethoxy)benzene instead of butanediol as chain lengthening agent. The resultant polyurethane had a hard segment content of 13% and a Shore A hardness of 76.
Example 7 A polyether ester haYing an OH number of 34.7 prepared from the dimeric acid from Example I and diethylene glycol was used as component tb). The resultant polyurethane o had a hard segment content of 22.4% and Shore A hardness of 68.
Example 8 A polyester having an OH number of 20 prepared from the dimeric acid from Example I and hexanediol was used as component (b). The resultant polyurethane had a hard segment content of 14.2% and Shore A hardness of 53.
Example 9 A thermoplastic polyurethane was prepared as described in Example 1 except that the polyester derivative (b) had an OH number of 45.7. The resultant thermoplastic polyurethane had a hard segment content of 27.5%. The interfacial tension of this polyurethane with water was 24.6 mN/m.
Conventional thermoplastic polyurethanes have a higher interfacial tension and are therefore less suitable for 2S medical implants.
Examp,le~ 10 A polyester prepared from the dimeric fatty acid of Example 1 and hexanediol (OH number 30) was used. In addition, bis(4-isocyanatocyclohexyl)methane was used instead of MDI. As chain lengthening agent, butanediol was used. The following results were obtained for the resultant polyurethane:
% Hard segment: 31 Shore A hardness: 71 % Elongation 500 Tensile strength: 2~.7 MPa Mo3449 2 ~ ~'3 ~
-]O-The elastomer obtained was transparent.
Example 11 Polyurethanes were prepared as in Example 10 except for using MDI as the polyisocyanate and different percentages 5 by weight of the hard segment (as indicated). The resultant polyurethanes had the following properties:
ExamDle 11a Example 11b % Hard segmen~: 25.8 16.1 Shore A hardness: 65 34 % Elongation 744 822 Tensile strength: 17 MPa 12 MPa Tear resistance (DIN 53,515)25 KN/m20 KN/m % Compression set (24 h, 70C; DIN 53,517) 45 52 ExamDle 12 Example 11 was repeated using a hard segment percentage by weight of 18.3. The resultant polyurethane (compound 12a) had the following properties:
Shore A hardness: 59 20 . % Elongation 830 Tensile strength: 13 MPa As a comparison, a polyurethane elastomer (compound 12b) hav;ng a hard segment percentage of 29% was prepared by the general method described above from the polyesterdiol of 25 adipic acid (described in Example 1).
The permanent elongation of polyurethanes 12a and 12b were measured. The results are entered into the following Table:
12a 12b 12a 12b 12a 12b 12a 12b % Elongation100 100150 150 200 200 250 250 Permanent elongation 7 12 12 20 21 48 30 78 Mo3449
156,665 (corresponding to U.S. Patent 4,602 079). The proportion of dimeric fatty acid is at most 35% by weight. The use of higher proportions of predominantly dimeric fatty acid is not obvious since it is known that large proportions of polydiols having a predominantly aliphatic character, such as OH-terminated polybutadiene or its hydrogenated form, give rise to materials that have only moderate mechanical properties ("strength") caused by poor miscibility with the hard phase.
Houben-Weyl, Handbuch der organischen Chemie, Volume E20, pages o 1569 and 1599.
Isocyanate-modified polyesters based on a glycol and a polymeric fatty acid are disclosed in U.S. Patent 3,264,236.
Soft polyurethane elastomers having high dimensional stability under heat, excellent flexibility in the cold, and high elasticity have not, however, been previously known in the art.
It is an object of the present invention to provide soft, highly elastic polyurethane elastomers having high dimensional stability under heat and excellent flexibility in the cold.
SUMMARY OF THE INVENTION
This invention relates to thermoplastic polyurethanes that are at least substantially linear in structure prepared by a process comprising reacting (aJ organic polyisocyanates;
(b) at least one polyester derivative having at least two isocyanate reactive hydrogen atoms, wherein said polyester derivative is a polyester of an ~ dicarboxylic acid containing a total of at least 16 carbon atoms and a non-vicinal diol, in an amount such that the proportion of the ~,~-dicarboxylic acid is greater than 35% by weight based on the total quantity of thermoplastic polyurethane;
and (c) chain lengthening agents having no phenolic OH groups.
Mo3449 2 ~ 2 ~
Catalysts, other known addltives, and other isocyanate-reactive compounds having a molecular weight greater than 400 may optionally be included in the preparation of the thermoplastic polyurethanes of the invention.
This invention further relates to a process for the preparation of thermoplastic polyurethanes having a substantially linear structure by the reaction of the organic polyisocyanates (a) with the polyester derivatives (b) and the chain lengthening agents (c).
Yet another object of this invention is the use of the thermoplastic polyurethanes according to the invention for medical purposes.
DETAILED DESCRIPTION OF THE INVENTION
In a preferred embodiment, the thermoplastic polyurethanes according to the invention have a hardness of less than about 80 Shore A, preferably less than 75 Shore A.
These thermoplastic polyurethanes are substantially linear and preferably have a volume flow index ("MVI") of at least 0.3 cm3/10 min (preferably at least 1 cm3/10 min), as determined at l9O-C with a testing force of 10 kp (DIN 53735; ISO 1132).
Preferred polyester derivatives (b) are polyesters, polyester carbonates, polyetheresters, and polyetherester carbonates containing terminal OH or NH2 groups. Particularly preferred polyesters (b) have an acid number below about 2 and a hydroxyl number of from about 11 to about 170.
Preferred ~ dicarboxylic acids used to prepare the polyester derivatives (b) include dimeric fatty acids obtained by reductive dimerization of unsaturated aliphatic monocarboxylic acids, preferably monocarboxylic acids having about 8 to about 22 carbon atoms and most preferably oleic acids. The trimer content formed in the reaction is no more than about 5% by weight based on the dimeric fatty acid, preferably no more than 1.5% by weight.
The polyester derivatives (b) to be used according to the invention may be obtained in known manner by condensation Mo3449 2~2~
of ~ dicarboxylic acids with non-vicinal diols, optionally with the addition of diaryl or dialkyl carbonates or phosgene.
The OH end groups obtained in the reaction may optionally be replaced by NH2 groups.
~he polyester derivatives to be used according to the invention may contain other aliphatic dicarboxylic acids in addition to the dimeric acids (for example, glutaric acid, adipic acid, suberic acid, azelaic acid, sebacic acid, dodecane diacid, or mixtures thereof), but pure dimeric acid is o preferably used. Examples of non-vicinal diols suitable for the condensation reaction include ethylene glycol, 1,3- and 1,2-propanediol, di-, tri-, tetra-, and octa-ethylene glycol, dipropylene glycol, tripropylene glycol, 1,4-butanediol, 1,3-and 1,5-pentanediol, 2,2-dimethyl-1,3-propanediol, 1,6-hexanediol, and higher, optionally branched, aliphatic diols. The molecular weights of components (b) may be from about 700 to about 10,000.
The organic polyisocyanates (a) include those used in previously known processes and are described e.g. in 20 . Kunststoff-handbuch, Volume VII, Polyurethane, Hanser Verlag, Munich, 1983, or in Houben-Weyl, Makromolekulare Stoffe, Volume E20. Aromatic or aliphatic diisocyanates, especially bis(iso-cyanatophenyl)methane, are preferably used. Other diiso-cyanates, however, may also be used, including aliphatic diisocyanates such as tetra- or hexamethylene diisocyanate, trimethylhexamethylene diisocyanate; cycloaliphatic diiso-cyanates such as cyclohexyl diisocyanate, isophorone diiso-cyanate or dicyclohexylmethane diisocyanate; or aromatic diiso-cyanates such as benzene diisocyanate, toluene diisocyanate, dichlorodiphenylmethane diisocyanate, dimethyldiphenylmethane diisocyanate, or dibenzyldiisocyanate.
The chain lengthening agents (c) are preferably bifunctional polyols such as ethylene glycol, propylene glycol, 1,4-butanediol, 1,5-pentanediol, 1,6-hexanediol, 1,4-cyclo-hexanedimethanol, hydroquinone-bis(2-hydroxyethyl) ether, and Mo3449 2~2 1,5-bis(2-hydroxyethoxy)naphthalene. The preferred ch~in lengthening agents have a molecular weight of from about 32 to about 399~ preferably from 62 to 220.
In one particularly preferred embodiment~ polyiso-cyanate (a~ is an isocyanate based on diphenylmethane and the chain lengthening agent (c) is butanediol.
In another preferred embodiment, components (a), (b), and (c) are substantially bifunctional and from about 0.9 to about 1.2 equivalents of isocyanate-reactive compounds are used per isocyanate equivalent.
Known catalysts, such as organic or inorganic tin compounds, amines, or alkali metal compounds, are optionally used for the preparation of polyurethanes. Other additives, such as blowing agents, stabilizers, emulsifiers, dyes, pigments, and fillers may also be used in known manner.
The thermoplastic polyurethanes according to the invention may be prepared by various methods. In one preferred embodiment, the polyurethane thermoplast is prepared by the band or screw process. See Becker/Braun, Kunststoff-Handbuch, Volume 7, Polyurethane, Chapter 8.2.1, pages 428 et seq, Carl Hanser Verlag, Munich, Vienna, 1983. A double screw kneading machine is used in a preferred embodiment.
The polyurethane-forming components may be introduced into the extruder at one feed point or at several feed points.
The components may be introduced into the screw machine either separately or as a pre-mix. See German Offenlegungsschrift 2,842,806. In a particularly preferred process, a prepolymer is first formed from isocyanate (a) and polyester derivative (b) and the chain lengthening agent is then added to the 30 prepolymer.
Apart from the low hardness and high elasticity compared with polyurethane elastomers prepared without dimeric fatty acids or with only small proportions of dimeric fatty acids, the polyurethane elastomers according to the invention 35 are also distinguished by their good compatibility with body Mo3449 2~ 2 ~. Q ~ ~
tissues and blood, which is due to the reduced surface tension, and their great durability when in contact with body fluids.
The elastomers of the invention are therefore particularly suitable for the manufacture of medical equipment such as blood bags, catheters, pacemaker leads, and artificial blood vessels or tubes to be inserted intravenously. Pharmacologically valuable substances may be incorporated in the materials, in particular anti-coagulants such as heparin, immunosuppressive drugs, antibiotics, or other known pharmacologically active o ingredients described, for example, in Polymer Science and Technology, Volume 34, "Polymers in Medicine IIn, Plenum Press, New York, 1983.
The following examples further illustrate details for the preparation of the compositions of this invention. The invention, which is set forth in the foregoing disclosure, is not to be limited either in spirit or scope by these examples.
Those skilled in the art will readily understand that known variations of the conditions and processes of the following preparative procedures can be used to prepare these 20 - compositions. Unless otherwise noted, all temperatures are degrees Celsius and all percentages are percentages by weight.
EXAMPLES
General Method of Preparation: Polyester component (b) (having compositions as described below) (0.~5 mole) was reacted with the total quantity of bis(4-isocyanatophenyl)-methane ("MDI~) (or other polyisocyanate, if indicated) at 100-C to form a prepolymer. The quantity of chain lengthening agent (c) equivalent to the remaining NCO groups was added to the melt at 110 C and the mi~ture was briefly degassed, poured into a mold, and tempered at llO-C for 8 hours. Plates 1 or 2 mm in thickness were produced by compression molding at 200-C
for determination of mechanical properties.
Comparison examples were prepared using a polyester diol of adipic acid and butanediol (OH number of 49.7) instead of component (b).
Mo3~49 2~23~ ~
The low hardness of the polyurethanes according to the invention is evident from the following Examples.
~xamPle 1 The procedure described above was carried out using 5 butanedio~ as the chain lengthening agent (c) and as component (b) a polyester having an OH number of 49.2 prepared from (1) hydrogenated dimeric fatty acid with acid number 197 (trimer content 1% and monomer content 0.1%) and (2) butanediol. The dimeric fatty acid had been obtained by dimerization of fatty acids and contains 36 carbon atoms (CAS Registry Number 68783-41-5, iodide value of 7).
The data listed in the following Table show that the thermoplastic polyurethanes obtained were surprisingly soft, in view of the percentage content of hard segment.
g MDI g Butane- Polyester X Hard Hardness diol OH number segment Shore A Shore D
37.5 9 49.2 28.92 80 28 13.5 49.2 35.71 85 30 62.5 18 50.7 41.32 89 39 22.5 50.7 46.88 92 44 Similar properties were obtained using as component ~b) a similar polyester having an OH number of 50.7.
When an adipic acid polyester having an OH number of 49.7 is used instead of the polyester derivative to be used according to the invention, the product obtained with the same proportion of hard segment is less soft.
Example 2 A thermoplastic polyurethane was prepared as described in Example 1 except that the polyester (b) was a polyester having an OH number 37. The resultant thermoplastic polyurethane had the following properties:
Mo344g 2 ~
% Hard segment: 23.5 Shore A hardness: 72 Tensile strength: 17 MPa Melting point of hard segment: 150C
Brittleness point: -40C
Example 3 A thermoplastic polyurethane was prepared as described in Example 1 except that the polyester (b) was a polyester having an OH number 28 prepared from the dimeric fatty acid from Example 1 and neopentyl glycol. The resultant thermoplastic polyurethane had the following properties:
% Hard segment: 19 Shore A hardness: 61 Tensile strength: 12 MPa Melting point of hard segment: 145C
Brittleness point: -40C
Thermoplastic polyurethanes having the degree of softness shown in Examples 2 and 3 are not obtained when conventional polyols are used. A polyurethane prepared from 20 the comparison polyester of Example 1 and containing a hard segment proportion of 20.8% by weight had a Shore A hardness of 94.
Example 4 A polyester having an OH number of 34.8 prepared from 25 the dimeric acid from Example 1 and ethylene glycol was used as component (b). The resultant polyurethane had a hard segment content of 22.4% and a Shore A hardness of 60.
Example 5 A polyester having an OH number of 27.0 prepared from 30 the dimeric acid from Example I and hexanediol was allowed to react with hexamethylene diisocyanate instead of bis(4-iso-cyanatophenyl)methane with the aid of butanediol as chain lengthening agent. The resultant product had a hard segment content of 14.2% and a Shore A hardness of 66.
Mo3449 2 ~ Q ~ ~
Example 6 Example 5 was repeated but using 1,4-bis(2-hydroxy-ethoxy)benzene instead of butanediol as chain lengthening agent. The resultant polyurethane had a hard segment content of 13% and a Shore A hardness of 76.
Example 7 A polyether ester haYing an OH number of 34.7 prepared from the dimeric acid from Example I and diethylene glycol was used as component tb). The resultant polyurethane o had a hard segment content of 22.4% and Shore A hardness of 68.
Example 8 A polyester having an OH number of 20 prepared from the dimeric acid from Example I and hexanediol was used as component (b). The resultant polyurethane had a hard segment content of 14.2% and Shore A hardness of 53.
Example 9 A thermoplastic polyurethane was prepared as described in Example 1 except that the polyester derivative (b) had an OH number of 45.7. The resultant thermoplastic polyurethane had a hard segment content of 27.5%. The interfacial tension of this polyurethane with water was 24.6 mN/m.
Conventional thermoplastic polyurethanes have a higher interfacial tension and are therefore less suitable for 2S medical implants.
Examp,le~ 10 A polyester prepared from the dimeric fatty acid of Example 1 and hexanediol (OH number 30) was used. In addition, bis(4-isocyanatocyclohexyl)methane was used instead of MDI. As chain lengthening agent, butanediol was used. The following results were obtained for the resultant polyurethane:
% Hard segment: 31 Shore A hardness: 71 % Elongation 500 Tensile strength: 2~.7 MPa Mo3449 2 ~ ~'3 ~
-]O-The elastomer obtained was transparent.
Example 11 Polyurethanes were prepared as in Example 10 except for using MDI as the polyisocyanate and different percentages 5 by weight of the hard segment (as indicated). The resultant polyurethanes had the following properties:
ExamDle 11a Example 11b % Hard segmen~: 25.8 16.1 Shore A hardness: 65 34 % Elongation 744 822 Tensile strength: 17 MPa 12 MPa Tear resistance (DIN 53,515)25 KN/m20 KN/m % Compression set (24 h, 70C; DIN 53,517) 45 52 ExamDle 12 Example 11 was repeated using a hard segment percentage by weight of 18.3. The resultant polyurethane (compound 12a) had the following properties:
Shore A hardness: 59 20 . % Elongation 830 Tensile strength: 13 MPa As a comparison, a polyurethane elastomer (compound 12b) hav;ng a hard segment percentage of 29% was prepared by the general method described above from the polyesterdiol of 25 adipic acid (described in Example 1).
The permanent elongation of polyurethanes 12a and 12b were measured. The results are entered into the following Table:
12a 12b 12a 12b 12a 12b 12a 12b % Elongation100 100150 150 200 200 250 250 Permanent elongation 7 12 12 20 21 48 30 78 Mo3449
Claims (11)
1. A thermoplastic polyurethane that is at least substantially linear in structure prepared by a process comprising reacting (a) an organic polyisocyanate;
(b) at least one polyester derivative having at least two isocyanate reactive hydrogen atoms, wherein said polyester derivative is a polyester of an .alpha.,.omega.-dicarboxylic acid containing a total of at least 16 carbon atoms and a non-vicinal diol, in an amount such that the proportion of the .alpha.,.omega.-dicarboxylic acid is greater than 35% by weight based on the total quantity of thermoplastic polyurethane;
and (c) a chain lengthening agent having no phenolic OH groups.
(b) at least one polyester derivative having at least two isocyanate reactive hydrogen atoms, wherein said polyester derivative is a polyester of an .alpha.,.omega.-dicarboxylic acid containing a total of at least 16 carbon atoms and a non-vicinal diol, in an amount such that the proportion of the .alpha.,.omega.-dicarboxylic acid is greater than 35% by weight based on the total quantity of thermoplastic polyurethane;
and (c) a chain lengthening agent having no phenolic OH groups.
2. A thermoplastic polyurethane according to Claim 1 wherein the polyester derivative (b) is a polyester, polyester carbonate, polyether ester, or polyether ester carbonate containing terminal OH or NH2 groups.
3. A thermoplastic polyurethane according to Claim 1 wherein the .alpha.,.omega.-dicarboxylic acid is a dimer of an unsaturated aliphatic monocarboxylic acid having at least 8 carbon atoms and having a trimer content of no more than 5% by weight.
4. A thermoplastic polyurethane according to Claim 1 wherein the polyester derivative (b) has an acid number below 2 and a hydroxyl number of from 11 to 170.
5. A thermoplastic polyurethane according to Claim 1 wherein polyisocyanate (a) is an isocyanate based on diphenylmethane and the chain lengthening agent (c) is butanediol.
6. A thermoplastic polyurethane according to Claim 1 wherein components (a) and (c) are substantially bifunctional and from about 0.9 to about 1.2 equivalents of isocyanate-reactive compounds are used per isocyanate equivalent.
Mo3449
Mo3449
7. A thermoplastic polyurethane according to Claim 1 wherein the thermoplastic polyurethane has a hardness of less than 80 Shore A.
8. A process for the preparation of a thermoplastic polyurethane having a substantially linear structure comprising reacting (a) an organic polyisocyanate;
(b) at least one polyester derivative having at least two isocyanate reactive hydrogen atoms, wherein said polyester derivative is a polyester of an .alpha.,.omega.-dicarboxylic acid containing a total of at least 16 carbon atoms and a non-vicinal diol, in an amount such that the proportion of the .alpha.,.omega.-dicarboxylic acid is greater than 35% by weight based on the total quantity of thermoplastic polyurethane;
and (c) a chain lengthening agent having no phenolic OH groups.
(b) at least one polyester derivative having at least two isocyanate reactive hydrogen atoms, wherein said polyester derivative is a polyester of an .alpha.,.omega.-dicarboxylic acid containing a total of at least 16 carbon atoms and a non-vicinal diol, in an amount such that the proportion of the .alpha.,.omega.-dicarboxylic acid is greater than 35% by weight based on the total quantity of thermoplastic polyurethane;
and (c) a chain lengthening agent having no phenolic OH groups.
9. A process according to Claim 8 comprising first reacting polyisocyanate (a) and polyester derivative (b) to form a prepolymer and then adding chain lengthening agent (c) to said prepolymer.
10. A method comprising manufacturing medical equipment from a thermoplastic polyurethane according to Claim 1.
11. A method comprising incorporating pharmacologically valuable substances into a thermoplastic polyurethane according to Claim 1.
Mo3449
Mo3449
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19893930523 DE3930523A1 (en) | 1989-09-13 | 1989-09-13 | POLYURETHANE ELASTOMERS WITH LOW HOLDER |
DEP3930523.6 | 1989-09-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2025010A1 true CA2025010A1 (en) | 1991-03-14 |
Family
ID=6389307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2025010 Abandoned CA2025010A1 (en) | 1989-09-13 | 1990-09-10 | Polyurethane elastomers of low hardness |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0417553A3 (en) |
JP (1) | JPH03119018A (en) |
CA (1) | CA2025010A1 (en) |
DE (1) | DE3930523A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6022939A (en) * | 1994-12-23 | 2000-02-08 | Bayer Aktiengesellschaft | Thermoplastic polyurethanes with improved melt flow |
US6790916B2 (en) | 2002-02-23 | 2004-09-14 | Bayer Aktiengesellschaft | Process for the preparation of soft, low-shrinkage, thermoplastic polyurethane elastomers which can be easily released from the mold |
WO2021110623A1 (en) * | 2019-12-03 | 2021-06-10 | Basf Se | A medical tubing comprising thermoplastic polyurethane |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1264880B1 (en) * | 1993-06-24 | 1996-10-17 | Tema Srl | THERMOPLASTIC, ELASTIC, GUMMOUS POLYURETHANES WITH SHORE A HARDNESS LESS THAN 80 |
US5795633A (en) * | 1994-08-22 | 1998-08-18 | Nippon Zeon Co., Ltd. | Material composition and shaped article |
DE4446332A1 (en) * | 1994-12-23 | 1996-06-27 | Bayer Ag | Thermoplastic polyurethanes with improved melt flow |
DE19632925A1 (en) * | 1996-08-16 | 1998-02-19 | Bayer Ag | Responsive masses with a long pot life |
DE19939112A1 (en) * | 1999-08-18 | 2001-02-22 | Basf Ag | Thermoplastic polyurethanes |
CA2899226C (en) * | 2013-02-04 | 2020-08-25 | Lubrizol Advanced Materials, Inc. | Clear hydrophobic tpu |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3264236A (en) * | 1959-06-22 | 1966-08-02 | Thiokol Chemical Corp | p-tolylene dhsocyanate modified polyester polymer and method of making the same |
US3689443A (en) * | 1967-12-13 | 1972-09-05 | Basf Wyandotte Corp | Thermoplastically processable polyurethane elastomers |
CA1030293A (en) * | 1973-04-16 | 1978-04-25 | Arthur J. Coury | Polyurethanes and the coating of glass containers |
US4423179A (en) * | 1981-09-29 | 1983-12-27 | Inmont | Dimer acid based polyurethane coating compositions |
-
1989
- 1989-09-13 DE DE19893930523 patent/DE3930523A1/en not_active Withdrawn
-
1990
- 1990-08-30 EP EP19900116603 patent/EP0417553A3/en not_active Withdrawn
- 1990-09-10 CA CA 2025010 patent/CA2025010A1/en not_active Abandoned
- 1990-09-11 JP JP2239137A patent/JPH03119018A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6022939A (en) * | 1994-12-23 | 2000-02-08 | Bayer Aktiengesellschaft | Thermoplastic polyurethanes with improved melt flow |
US6790916B2 (en) | 2002-02-23 | 2004-09-14 | Bayer Aktiengesellschaft | Process for the preparation of soft, low-shrinkage, thermoplastic polyurethane elastomers which can be easily released from the mold |
WO2021110623A1 (en) * | 2019-12-03 | 2021-06-10 | Basf Se | A medical tubing comprising thermoplastic polyurethane |
Also Published As
Publication number | Publication date |
---|---|
JPH03119018A (en) | 1991-05-21 |
EP0417553A2 (en) | 1991-03-20 |
EP0417553A3 (en) | 1991-05-02 |
DE3930523A1 (en) | 1991-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR0157982B1 (en) | Thermoplastic polyurethanes | |
EP0644215B1 (en) | Bis(N-alkylaminocyclohexyl)methanes as curing agents for polyurethanes and polyureas | |
JP3097854B2 (en) | Method for producing polyurethanes | |
EP1805239B1 (en) | A polyurethane elastomer of high clarity | |
JP2727016B2 (en) | Liquid polyisocyanate composition, method for its production and its use for producing a flexible polyurethane foam | |
US3640967A (en) | Process for the preparation of polyurethanes | |
CN1328298C (en) | Polyurethane compounds and articles prepared therefrom | |
CA1338884C (en) | Urethane polymer alloys with reactive epoxy functional groups | |
US4892920A (en) | Process for the preparation of cyclohexanediisocyanate containing polyisocyanate prepolymers and polyurethanes having high temperature performance | |
US4546167A (en) | P-TMXDI Polyurethane elastomers with good compression set properties | |
US5246977A (en) | Microcellular polyurethane polymers prepared from isocyanate-terminated poly(oxytetramethylene) glycol prepolymers | |
EP0746591A1 (en) | Thermoplastic urethane elastomeric alloys | |
EP0595501B1 (en) | High impact polyurethane | |
CA2025010A1 (en) | Polyurethane elastomers of low hardness | |
US5942593A (en) | Cycloaliphatic thermoplastic polyurethane elastomers | |
PL169691B1 (en) | Method of obtaining a polyurethane polymer | |
US4020001A (en) | Diol curative for polyurethane | |
US3933938A (en) | Grafted polyether diol-based thermoplastic urethane elastomer | |
US20200190246A1 (en) | Impact-resistant thermoplastic polyurethanes, production and use thereof | |
JPH06298893A (en) | Production of polyurethane resin | |
TW202206496A (en) | Solvent-free polyurethane material and middle sole prepared thereof | |
JP3608329B2 (en) | Polyisocyanate for flexible polyurethane foam | |
CN112694588B (en) | Polyurethane polymer with hardness less than or equal to 60 Shore A and good wear resistance | |
JPH11255857A (en) | Preparation of soft polyurethane foam | |
JP4962085B2 (en) | Polyoxalate polyol and polyoxalate urethane derived therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |